Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Prepaid Assets (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Prepaid Assets readings, the most recent being $170.7 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 251.96% to $170.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $170.7 million, a 251.96% increase, with the full-year FY2025 number at $170.7 million, up 251.96% from a year prior.
  • Prepaid Assets hit $170.7 million in Q4 2025 for Neurocrine Biosciences, up from $68.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $170.7 million in Q4 2025 to a low of $33.8 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $88.4 million (2022), compared with a mean of $86.4 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 50.41% in 2024 and later surged 251.96% in 2025.
  • Neurocrine Biosciences' Prepaid Assets stood at $45.5 million in 2021, then surged by 73.85% to $79.1 million in 2022, then increased by 23.64% to $97.8 million in 2023, then tumbled by 50.41% to $48.5 million in 2024, then surged by 251.96% to $170.7 million in 2025.
  • The last three reported values for Prepaid Assets were $170.7 million (Q4 2025), $68.2 million (Q3 2025), and $120.7 million (Q2 2025) per Business Quant data.